Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
88 /100
CRITICAL RISK
Score updated Oct 13, 2026

MTNB — Matinas BioPharma Holdings, Inc. Dilution Risk Tracker

Track MTNB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MTNB — Get alerts when the score changes →

As of October 13, 2026, Matinas BioPharma Holdings, Inc. (MTNB) has a DilutionWatch DilutionScore of 88/100, rated CRITICAL dilution risk. Matinas BioPharma Holdings, Inc. has a market capitalization of $40.26M, 14.69M shares outstanding, 28 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $150.00M, 9.29M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
95
📊 Float Risk
77
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 70%
💰 Capital Raise model 75%
• Critical: only 1.1 months cash remaining
• Active shelf registration ($150M, 373% of market cap)
🔄 Reverse Split model est. 70%
• 50-day avg $0.60 below $1 exchange minimum
• Only 1 months cash — financial pressure
📜 Warrant Exercise model 60%
• Massive warrant overhang: 63% of shares outstanding
• Warrant risk score very high (90/100)
🔔 Track MTNB — Get forecast alerts →

Market Data

Market Cap$40.26M
Shares Outstanding14.69M
Float5.23M
Cash$1.26M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore88/100DilutionWatch score record
Shares Outstanding14.69MVerified float table or market cache
Public Float5.23MVerified float table or market cache
Market Cap$40.26MMarket data cache
Cash Runway1.1 monthsDilutionWatch score inputs
Shelf Capacity$150.00MSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants9.29MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 2, S-3 1, SC 13D/A 1, SC 13G 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 16.9% shares (2026Q1 vs prior)
28 institutional holders · 395.7K shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 80.2K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 65.2K shares
#3 CITADEL ADVISORS LLC 51.7K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest56.2K
Days to Cover1.0
% of Float1.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2018-03-16
4 INSIDER TRANSACTION 2026-08-13
SC 13D/A BENEFICIAL OWNERSHIP 2026-08-13
4 INSIDER TRANSACTION 2026-08-13
Full SEC filing analysis available with free account →

Recent News

Factual MTNB Dilution Snapshot

Matinas BioPharma Holdings, Inc. (MTNB) has a DilutionScore of 88/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

MTNB's DilutionScore is currently 88/100 (Critical risk), with 2 score changes tracked over 89 days. The score improved from 75/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202688/100CRITICAL13 days
Aug 24 – Sep 30, 202675/100HIGH38 days
Jul 16 – Aug 23, 202665/100HIGH38 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track MTNB Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment MTNB files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking MTNB — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MTNB
MTNB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.